Neutrophils in the Tumor Microenvironment

Trends in Immunology

Volumn 37, Issue 1, 2016, Pages 41-52

  Powell, Davalyn R ^a   Huttenlocher, Anna ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CANCER GROWTH; CELL MIGRATION; HUMAN; INFLAMMATION; NEUTROPHIL; NONHUMAN; REGULATORY MECHANISM; REVIEW; TISSUE INJURY; TUMOR INVASION; TUMOR MICROENVIRONMENT; CARCINOGENESIS; CELL MOTION; IMMUNOLOGY; MACROPHAGE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY);

CARCINOGENESIS; CELL MOVEMENT; INFLAMMATION; MACROPHAGES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; TUMOR MICROENVIRONMENT;

EID: 84952861791     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2015.11.008     Document Type: Review

References (115)

1. Kruger P., et al. Neutrophils: between host defence, immune modulation, and tissue injury. PLoS Pathog. 2015, 11:e1004651.
2. Nauseef W.M., Borregaard N. Neutrophils at work. Nat. Immunol. 2014, 15:602-611.
3. Kolaczkowska E., Kubes P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 2013, 13:159-175.
4. 2O reveals a human neutrophil lifespan of 5.4 days. Blood 2010, 116:625-627.
5. Lakshman R., Finn A. Neutrophil disorders and their management. J. Clin. Pathol. 2001, 54:7-19.
6. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 1986, 315:1650-1659.
7. Bekes E.M., et al. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am. J. Pathol. 2011, 179:1455-1470.
8. Acharyya S., et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 2012, 150:165-178.
9. Eruslanov E.B., et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J. Clin. Invest. 2014, 124:5466-5480.
10. Fridlender Z.G., et al. Polarization of tumor-associated neutrophil phenotype by TGF-β: "N1" versus "N2" TAN. Cancer Cell 2009, 16:183-194.
11. Zhang Q., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
12. Niethammer P., et al. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009, 459:996-999.
13. Yoo S.K., et al. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 2011, 480:109-112.
14. Lammermann T., et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 2013, 498:371-375.
15. McDonald B., et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010, 330:362-366.
16. Moles A., et al. A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse. J. Hepatol. 2014, 60:782-791.
17. Anzai A., et al. Adventitial CXCL1/G-CSF expression in response to acute aortic dissection triggers local neutrophil recruitment and activation leading to aortic rupture. Circ. Res. 2015, 116:612-623.
18. de Oliveira S., et al. Cxcl8 (IL-8) mediates neutrophil recruitment and behavior in the zebrafish inflammatory response. J. Immunol. 2013, 190:4349-4359.
19. Liu M., et al. Formylpeptide receptors mediate rapid neutrophil mobilization to accelerate wound healing. PLoS ONE 2014, 9:e90613.
20. Christoffersson G., et al. VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood 2012, 120:4653-4662.
21. LeBert D.C., et al. Matrix metalloproteinase 9 modulates collagen matrices and wound repair. Development 2015, 142:2136-2146.
22. Brancato S.K., Albina J.E. Wound macrophages as key regulators of repair: origin, phenotype, and function. Am. J. Pathol. 2011, 178:19-25.
23. Pase L., et al. Neutrophil-delivered myeloperoxidase dampens the hydrogen peroxide burst after tissue wounding in zebrafish. Curr. Biol. 2012, 22:1818-1824.
24. Wong S.L., et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat. Med. 2015, 21:815-819.
25. Schauer C., et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat. Med. 2014, 20:511-517.
26. Silva M.T. Macrophage phagocytosis of neutrophils at inflammatory/infectious foci: a cooperative mechanism in the control of infection and infectious inflammation. J. Leukoc. Biol. 2011, 89:675-683.
27. Hughes J., et al. Neutrophil fate in experimental glomerular capillary injury in the rat. Emigration exceeds in situ clearance by apoptosis. Am. J. Pathol. 1997, 150:223-234.
28. Buckley C.D., et al. Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J. Leukoc. Biol. 2006, 79:303-311.
29. Mathias J.R., et al. Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J. Leukoc. Biol. 2006, 80:1281-1288.
30. Woodfin A., et al. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat. Immunol. 2011, 12:761-769.
31. Tauzin S., et al. Redox and Src family kinase signaling control leukocyte wound attraction and neutrophil reverse migration. J. Cell Biol. 2014, 207:589-598.
32. Colom B., et al. Leukotriene B4-neutrophil elastase axis drives neutrophil reverse transendothelial cell migration in vivo. Immunity 2015, 42:1075-1086.
33. Hamza B., Irimia D. Whole blood human neutrophil trafficking in a microfluidic model of infection and inflammation. Lab Chip 2015, 15:2625-2633.
34. Hamza B., et al. Retrotaxis of human neutrophils during mechanical confinement inside microfluidic channels. Integr. Biol. 2014, 6:175-183.
35. Ellett F., et al. Defining the phenotype of neutrophils following reverse migration in zebrafish. J. Leukoc. Biol. 2015, Published online June 12, 2015. 10.1189/jlb.1183MA0315-1105R.
36. Stockley J.A., et al. Aberrant neutrophil functions in stable chronic obstructive pulmonary disease: the neutrophil as an immunotherapeutic target. Int. Immunopharmacol. 2013, 17:1211-1217.
37. Rao X., et al. The heterogenic properties of monocytes/macrophages and neutrophils in inflammatory response in diabetes. Life Sci. 2014, 116:59-66.
38. Caielli S., et al. Neutrophils come of age in chronic inflammation. Curr. Opin. Immunol. 2012, 24:671-677.
39. Battaglia M. Neutrophils and type 1 autoimmune diabetes. Curr. Opin. Hematol. 2014, 21:8-15.
40. Wright H.L., et al. The multifactorial role of neutrophils in rheumatoid arthritis. Nat. Rev. Rheumatol. 2014, 10:593-601.
41. Jensen H.K., et al. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol. 2009, 27:4709-4717.
42. Kuang D.M., et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J. Hepatol. 2011, 54:948-955.
43. Li Y.W., et al. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J. Hepatol. 2011, 54:497-505.
44. Ilie M., et al. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer 2012, 118:1726-1737.
45. Jensen T.O., et al. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma. Cancer 2012, 118:2476-2485.
46. Trellakis S., et al. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int. J. Cancer 2011, 129:2183-2193.
47. Fossati G., et al. Neutrophil infiltration into human gliomas. Acta Neuropathol. 1999, 98:349-354.
48. Rao H.L., et al. Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis. PLoS ONE 2012, 7:e30806.
49. Reid M.D., et al. Tumor-infiltrating neutrophils in pancreatic neoplasia. Mod. Pathol. 2011, 24:1612-1619.
50. Shen M., et al. Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS ONE 2014, 9:e98259.
51. Murphy P.M. Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin. Hematol. 1997, 34:311-318.
52. Raccosta L., et al. The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils. J. Exp. Med. 2013, 210:1711-1728.
53. Viola A., et al. The pros and cons of chemokines in tumor immunology. Trends Immunol. 2012, 33:496-504.
54. Zhou S.L., et al. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 2012, 56:2242-2254.
55. Zhou S.L., et al. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Lett. 2015, 358:124-135.
56. Moore R.J., et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat. Med. 1999, 5:828-831.
57. Coffelt S.B., et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 2015, 522:345-348.
58. Benevides L., et al. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Res. 2015, 75:3788-3799.
59. Antonio N., et al. The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J. 2015, 34:2219-2236.
60. Feng Y., et al. Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol. 2010, 8:e1000562.
61. Dumitru C.A., et al. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. Semin. Cancer Biol. 2013, 23:141-148.
62. Coussens L.M., et al. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000, 103:481-490.
63. Sandhu J.K., et al. Neutrophils, nitric oxide synthase, and mutations in the Mutatect murine tumor model. Am. J. Pathol. 2000, 156:509-518.
64. Gungor N., et al. Genotoxic effects of neutrophils and hypochlorous acid. Mutagenesis 2010, 25:149-154.
65. Tazawa H., et al. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am. J. Pathol. 2003, 163:2221-2232.
66. Wislez M., et al. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res. 2003, 63:1405-1412.
67. Finisguerra V., et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature 2015, 522:349-353.
68. Queen M.M., et al. Breast cancer cells stimulate neutrophils to produce Oncostatin M: potential implications for tumor progression. Cancer Res. 2005, 65:8896-8904.
69. Lauber S., et al. Novel function of Oncostatin M as a potent tumour-promoting agent in lung. Int. J. Cancer 2015, 136:831-843.
70. Nozawa H., et al. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12493-12498.
71. He S., et al. Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J. Pathol. 2012, 227:431-445.
72. Freisinger C.M., Huttenlocher A. Live imaging and gene expression analysis in zebrafish identifies a link between neutrophils and epithelial to mesenchymal transition. PLoS ONE 2014, 9:e112183.
73. 2. Curr. Biol. 2012, 22:1253-1259.
74. Song W., et al. Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals. Oncotarget 2015, 6:19290-19304.
75. Rotondo R., et al. IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer. Int. J. Cancer 2009, 125:887-893.
76. Davey M.S., et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J. Immunol. 2014, 193:3704-3716.
77. Takashima A., Yao Y. Neutrophil plasticity: acquisition of phenotype and functionality of antigen-presenting cell. J. Leukoc. Biol. 2015, 98:489-496.
78. Cools-Lartigue J., et al. Neutrophil extracellular traps in cancer progression. Cell. Mol. Life Sci. 2014, 71:4179-4194.
79. Berger-Achituv S., et al. A proposed role for neutrophil extracellular traps in cancer immunoediting. Front. Immunol. 2013, 4:48.
80. Demers M., et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:13076-13081.
81. Sangaletti S., et al. Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma. Cancer Discov. 2014, 4:110-129.
82. Mishalian I., et al. Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol. Immunother. 2013, 62:1745-1756.
83. Cools-Lartigue J., et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Invest. 2013, 123:3446-3458.
84. Jamieson T., et al. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 2012, 122:3127-3144.
85. Ginestier C., et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J. Clin. Invest. 2010, 120:485-497.
86. Khan M.N., et al. CXCR1/2 antagonism with CXCL8/interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis. Oncotarget 2015, 6:21315-21327.
87. Verbeke H., et al. Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis. Cancer Lett. 2011, 302:54-62.
88. Houghton A.M., et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat. Med. 2010, 16:219-223.
89. Ruffell B., et al. Cathepsin C is a tissue-specific regulator of squamous carcinogenesis. Genes Dev. 2013, 27:2086-2098.
90. Robertson A.L., et al. A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism. Sci. Transl. Med. 2014, 6:225ra229.
91. Wang Z., et al. Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils. Nat. Nanotechnol. 2014, 9:204-210.
92. Piccard H., et al. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit. Rev. Oncol. Hematol. 2012, 82:296-309.
93. Yan J., et al. Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells. Oncoimmunology 2014, 3:e950163.
94. Li B., et al. Yeast β-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. J. Immunol. 2006, 177:1661-1669.
95. Souto J.C., et al. Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors. Med. Res. Rev. 2011, 31:311-363.
96. Clarke S.J., et al. Use of inflammatory markers to guide cancer treatment. Clin. Pharmacol. Ther. 2011, 90:475-478.
97. Ozyalvacli G., et al. Diagnostic and prognostic importance of the neutrophil lymphocyte ratio in breast cancer. Asian Pac. J. Cancer Prev. 2014, 15:10363-10366.
98. Lian L., et al. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer. Cancer Biomark. 2015, Published online September 25, 2015. 10.3233/CBM-150534.
99. Yildirim M.A., et al. Roles of neutrophil/lymphocyte and platelet/lymphocyte ratios in the early diagnosis of malignant ovarian masses. Asian Pac. J. Cancer Prev. 2014, 15:6881-6885.
100. Azab B., et al. The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer. Cancer Biomark. 2014, 14:303-312.
101. Gao F., et al. Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma. Medicine 2015, 94:e639.
102. Moniaux N., et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br. J. Cancer 2008, 98:1540-1547.
103. Lim R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int. J. Cancer 2007, 120:2426-2434.
104. Yen J., et al. Zebrafish models of cancer: progress and future challenges. Curr. Opin. Genet. Dev. 2014, 24:38-45.
105. Blackburn J.S., Langenau D.M. Zebrafish as a model to assess cancer heterogeneity, progression and relapse. Dis. Model. Mech. 2014, 7:755-762.
106. Teng Y., et al. Evaluating human cancer cell metastasis in zebrafish. BMC Cancer 2013, 13:453.
107. Marques I.J., et al. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 2009, 9:128.
108. Veinotte C.J., et al. Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era. Dis. Model. Mech. 2014, 7:745-754.
109. Gabrilovich D.I., et al. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 2007, 67:425. author reply 426.
110. Brandau S., et al. Protumor and antitumor functions of neutrophil granulocytes. Semin. Immunopathol. 2013, 35:163-176.
111. Dumitru C.A., et al. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol. Immunother. 2012, 61:1155-1167.
112. Pillay J., et al. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cell. Mol. Life Sci. 2013, 70:3813-3827.
113. Youn J.I., et al. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 2012, 91:167-181.
114. Fridlender Z.G., et al. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS ONE 2012, 7:e31524.
115. Sagiv J.Y., et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 2015, 10:562-573.